Skip to main content
UK clinical trials - updated daily from ClinicalTrials.gov
TrialConnect
← Back to Search
UNKNOWNN/A

POWER Myocardial Fatigue Study: a Biomechanical Assessment of Contractility of Human Myocardium

Sponsor: University Hospitals Coventry and Warwickshire NHS Trust

NCT ID: NCT04899635

View on ClinicalTrials.gov ↗

At a glance

What the study gets you
Health checks and monitoring — no treatment given
Type of study
Observational (no treatment given)
Time in hospital
In-person visits at study sites — visit count not specified by the sponsor
Drug or intervention
In-vitro contractile fatigue protocol (other)
How long the study runs
Study runs about 44 months (dates as stated)
About the drug or intervention
In-vitro contractile fatigue protocol — other: Using contractility assays for muscle slices or the work-loop assay for isolated heart cells, the tissue preparation will undergo a series of contraction and relaxation under varying levels of preload, afterload, stimulation frequency and under other experimental conditions such as drug-induced inotropism.
Patient visit burden
Not specified by the sponsor
Type of study
Observing health over time
Ages
18 Years to 85 Years
Who
All
Number of participants
100
Started
2021-08-03
Last checked
2024-06

Plain English Summary

What is this study?

  • • Testing a new treatment for heart failure
  • • Clinical study - 100 participants
  • • To gain a comprehensive understanding of the biomechanical behaviour of human heart to explore the concept of myocardial fatigue in response to a temporal range of preload, afterload and drug-induced inotropy using in-vitro contractile assays

Who can take part?

  • • Ages 18 Years to 85 Years
  • • Diagnosed with heart failure

Where?

  • • Coventry - University Hospitals Coventry and Warwickshire

This is a simplified summary. Always discuss with your doctor before making any decisions.

About This Trial

To gain a comprehensive understanding of the biomechanical behaviour of human heart to explore the concept of myocardial fatigue in response to a temporal range of preload, afterload and drug-induced inotropy using in-vitro contractile assays.

More detail

A continuum of pathological states from fatigue, injury to damage of the myocardium has been proposed which complements the continuous spectrum of HF and reconciles the seemingly disparate plethora of mechanisms behind the pathophysiology of HF. Unlike skeletal muscle where mechanical stress can be readily removed upon fatigue, an impaired left ventricle continues to receive preload from the right ventricle and cannot rest, maintaining cardiac output only at the expense of increasing filling pressures (as in HF with preserved ejection fraction). If concurrently faced with high afterload from vascular stiffness, ventricular-arterial decoupling occurs, driving mechanical inefficiency and diminishing cardiac output (as in HF with reduced ejection fraction). Chances of recovery is linked to the degree of fatigue, cardiomyocyte loss and replacement with non-contractile fibrosis. Assuming that the myocardium is in a state of chronic fatigue before reaching advanced stages of fibrosis, cases such as aortic stenosis or hypertensive heart disease may potentially be reversible if the pathological load is promptly removed. This study will be re-synthesizing existing knowledge of the biomechanical behaviour of healthy and diseased cardiac myocytes and muscle in a new light of the theoretical constructs of myocardial fatigue, aligned with the existing energy-starvation theory. It will be a proof-of-concept study. Just as Frank-Starling's relationship between preload and cardiac output emerged from pre-clinical studies on muscle behaviour with subsequently major clinical implications, this study represents a necessary stepping stone to adding a new layer of insight into the pathophysiology of heart failure (HF).

Heart FailureFatigue; Muscle, HeartMyocardial DysfunctionExhaustion; Heart

How this trial compares with your answers

Answer 2 more questions to improve match

What we know so far

Condition· Matched your search
Age· Tell us your age for better matching
Gender· Tell us your sex for better matching

Still need:

  • • Tell us your age for better matching
  • • Tell us your sex for better matching

Preliminary match based on your answers. Full eligibility requires on-site assessment including medical history, physical exam, and lab tests. This does not guarantee enrolment.

Eligibility at a Glance

Key info

  • Age: 18 Years - 85 Years
  • Who can join: All genders

Biomarkers mentioned

recent positive

What the study is looking for

  • ✓All adult patients between 18 to 85-years old undergoing open-heart surgery who can undergo the consent process for...
  • ✓Healthy donor hearts that are deemed non-transplantable and consent received from a legal representative

Who cannot take part

  • ✗Patients who do not have the mental capacity to undergo the consent process
  • ✗For the safety of researchers, patients with evidence of ongoing blood-borne infections such as HIV, or a recent...
See the full criteria
Inclusion Criteria: * All adult patients between 18 to 85-years old undergoing open-heart surgery who can undergo the consent process for the study * Healthy donor hearts that are deemed non-transplantable and consent received from a legal representative Exclusion Criteria: This criterion is kept to a minimum since the availability of human myocardial samples is finite and dependent on the limited number of patients undergoing cardiac surgery annually within the local hospital. * Patients who do not have the mental capacity to undergo the consent process * For the safety of researchers, patients with evidence of ongoing blood-borne infections such as HIV, or a recent positive test for COVID-19 (within 10 days of last PCR test).

Where Is This Study? (1 UK site)

University Hospitals Coventry and Warwickshire

Coventry CV22DX, United Kingdom

Recruiting
Site contact (verified)
Prithwish BanerjeePrincipal Investigator

How to Get in Touch

Patrick Tran

Sponsor contact

CONTACT

02476964000 patricktranphd@gmail.com

Patrick Tran

Sponsor contact

CONTACT

+442476965689 patrick.tran2@uhcw.nhs.uk
Data sourced from ClinicalTrials.gov · Last verified: 2024-06